Losses of expression of the antigens A, Leaand Lexand over-expression of Leyin carcinomas and HG-SIL of the uterine cervix

Diagnostic Pathology

Volumn 3, Issue 1, 2008, Pages

  Moro Rodríguez, Ernesto ^a   Álvarez Fernández, Emilio ^b  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 52349120740     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-3-38     Document Type: Article

References (47)

1. Preface to Carbohydrate Pathology. S-I Hakomori, Acta Path Mic Sc 1992 100 Suppl 27 18 27 1520529
2. Deletion of histo-blood group A and B antigens and expression of incompatible A antigen in ovarian carcinoma. R Metoki K Kakudo Y Tsuji N Teng H Clausen S-I Hakomori, J Natl Cancer I 1989 81 15 1151 1157 10.1093/jnci/81.15. 1151
3. ABH and related histo-blood group antigens; inmunohistochemical differentiation in carrier isotypes and their distribution. H Clausen S Hakomori, Vox Sang 1989 56 1 20 2464874
4. Basic biochemistry of cell surface carbohydrates and aspects of the tissue distribution of histo-blood group ABH and related glycosphingolipids. J Holgersson ME Breimmer BE Samuelsson, APMIS Suppl 1992 27 18 27 1520526
5. General concept of tumor-associated carbohydrate antigens: Their chemical, phisical and enzymatic basis. In: Gangliosides and Cancer. S-I Hakomori, V.C.H, Oettgen HF, 1989 58 68
6. Loss of blood group ABO-related antigen expression in urothelium from pathients with chronic cistitis. TF Orntoft H Hvid H Clauser, Lab Invest 1989 60 2 305 310 2644485
7. Carbohydrate changes in bladder carcinomas. TF Orntoft, Acta Path Mic Sc 1992 100 Suppl 27 181 187 1520527
8. Relationship of epidermal growth factor receptor detectability with the ABH blood group antigens. Emphasis on normal and neoplastic urothelium. C Limas, Am J Pathol 1991 139 1 131 137 1713019
9. Carbohydrates in oral epithelia and secretion: Variation with cell differentiation. U Mandel, Acta Path Mic Sc 1992 100 Suppl 27 119 129 1520521
10. Simple mucine-type carbohydrate antigens (Tn, Sialosyl-Tn and T) in gastric mucosa, carcinomas and metastasis. L David JM Nesland H Clausen F Carneiro M Sobrinho-Simoes, APMIS Suppl 1992 27 162 172 1381596
11. Carbohydrate changes in colon carcinoma. S Itzkowitz, Acta Path Mic Sc 1992 100 Suppl 27 173 180
12. Fucosylated Type-2 chain polylactosamine antigens in human lung cancer. K Zenita Y Kirihata A Kitahara K Shigeta K Higuchi K Hirashima T Murachi M Miyake T Takeda R Kannagi, Int J Can 1988 41 3 344 349 10.1002/ijc.2910410304 2831158
13. Lectin histochemistry of normal bronchopulmonary tissues and common forms of bronchogenic carcinoma. E Alvarez-Fernández L Carretero- Albĩana, Arch Pathol Lab Med 1990 114 475 481 2334254
14. Expression of blood group antigens by normal bronchopulmonary tissues and common forms of pulmonary carcinomas. E Alvarez-Fernández L Carretero-Albĩana, Arch Pathol Lab Med 1991 115 42 49 1846285
15. Expression of blood-group antigen A-a favorable prognostic factor in non-small-cell lung cancer. JS Lee JY Ro AA Sahin WK Hong BW Brown CF Mountain WN Hittelman, N Engl J Med 1991 324 16 1084 1090 1848917
16. Carbohydrate antigens in human lung carcinomas. O Nilsson, Acta Path Mic Sc 1992 100 Suppl 27 149 161 1520524
17. Isoantigens A, B and H in benign and malignant lesions of the cervix. I Davidsohn S Kovarik LY Ni, Arch Pathol 1969 87 3 306 314 5766256
18. Isoantigens ABO in cervical neoplasia. A Stalf RF Mattingly, Gynecol Oncol 1972 1 26 35 10.1016/0090-8258(72)90004-2 4669441
19. Isoantigens ABH in cervical intraepithelial neoplasia. PH Lill HJ Norris AI Rubenstone M Chang-Lo I Davidsohn, Am J Clin Pathol 1976 66 5 767 774 983985
20. Loss of blood isoantigens in exfoliated cells during the progression of CIN demonstrated by monoclonal antibody staining. TR Himes CS Ernst I Koprowska, Acta Cytol 1986 30 5 461 468 2430389
21. The expression of Lewis(a) and Lewis(b) antigens reflects changes in fucosylation between normal and neoplastic cervical squamous epithelium. DSA Sanders DM Milne MA Kerr, J Pathol 1990 162 1 23 28 10.1002/path.1711620106 2231188
22. Clinical value of sialyl Tn antigen in patients with gynecologic tumors. M Inoue H Ogawa K Nakanishi O Tanizawa K Karino J Endo, Obstet Gynecol 1990 75 6 1032 1036 2342728
23. Cyclin/PCNA is the auxiliary protein of DNA polimerase-delta. R Bravo R Frank PA Blundell H Macdonald-Bravo, Nature 1987 326 6112 515 517 10.1038/326515a0 2882423
24. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. G Prelich CK Tan M Kostura MB Mathews AG So KM Downey B Stillman, Nature 1987 326 6112 517 520 10.1038/326517a0 2882424
25. Clinical implications of the p53 tumor-suppressor gene. CC Harris M Hollstein, N Engl J Med 1993 329 18 1318 1327 10.1056/NEJM199310283291807 8413413
26. The yin and yang of p53 in cellular proliferation. W Deppert, Semin Cancer Biol 1994 5 3 187 202 7948947
27. Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating cell nuclear antigen expression. WE Mercer MT Shields D Lin E Appella SJ Ullrich, Proc Natl Acad Sci USA 1991 88 1958 1962 1705714 10.1073/pnas.88.5.1958
28. Cell cycle. p21 inhibits cyclin shock. J Pines, Nature 1994 369 520 521 10.1038/369520a0 7911227
29. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. S Waga GJ Hannon D Beach B Stillman, Nature 1994 369 574 578 10.1038/369574a0 7911228
30. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. M Scheffner A Wearness JM Huibregtse AJ Levine PM Howlew, Cell 1990 63 1129 1136 10.1016/0092-8674(90)90409-8 2175676
31. Association of human papillomavirus types 16 and 18 E6 proteins with p53. BA Werness AJ Levine PM Howley, Science 1990 248 4951 76 79 10.1126/science.2157286 2157286
32. Detection of human papilloma virus in paraffin-embedded tissue using the polymerasa chain reaction. DK Shibata N Arnheim WJ Martin, J Exp Med 1988 167 1 225 230 2826637 10.1084/jem.167.1.225
33. The ploymerase chain reaction and the molecular genetic analysis of tissue biopsies. Diagnostic molecular pathology. A practical approach. CS Herrington JD NcGree DK Shibata, Oxford University Press 1992 II 86 111
34. Isolation, physicochemical characterization and carbohydrate-binding specificity of lectins. IJ Goldstein RD Poretz, The Lectins: Properties; Functions and Applications in Biology and Medicine FL. Academic Press Inc. Orlando 1986 33 247
35. Glycosphingolipids as differentiation-dependent, tumor-associated markers and as regulatiors of cell proliferation. S-I Hakomori, Oncogenes and Growth Factors Amsterdam, New York, Oxford: Elsevier Science Publishers, Ralph A Bradshaw, Steve Prentis, 1987 218 226
36. Carbohydrate pathology. E Dabelsteen H Clausen, Acta Path Mic Sc 1992 100 Suppl (27) 18 27 1520529
37. ABO antigens in cancer. Detection with the mixed cell agglutination reaction. S Kovarik I Davidsohn R Stejskal, Arch Pathol 1968 86 1 12 21 5690174
38. Tissue isoantigens A, B and H in carcionma of the cervix uteri: Their clinical significance. S Gupta YN Gupta IJ Singh B Sanyal S Khanna A Rani, J Surg Oncol 1981 16 71 77 10.1002/jso.2930160111 7007740
39. Isoantigens loss in cervical neoplasia. Demonstration by immunohistofluorescence and immunoperoxidase techniques. T Bonfiglio MR Fenberg, Arch Pathol Lab Med 1976 100 307 310 57765
40. Isoantigens status in condyloma acuminata of the uterine cervix: An immunoperoxidase study. NC Mambo, Am J Clin Pathol 1983 79 2 178 181 6297292
41. Changes of blood antigens in premalignant and malignant lesions of human exocervix. C Stubbe Teglbjaerg B Norrild E Debelsteen, Acta Pathol Microbiol Immunol Scand [A] 1985 93 3 149 151 4013740
42. Immunohistochemistry of the blood A, B, H, isoantigens and Oxford Ca as prognostic markers for stage IB squamous cell carcinoma of the cervix. AC To SJ Soong HM Shingleton H Gore JA Wilkerson KD Hatch D Phillips JR Dollar, Cancer 1986 58 11 2435 2439
43. Differences in clinical significance of blood antigens A, B and H in carcinoma tissue in the uterine cervix. Y Sakamoto M Kamada M Irahara H Hasebe T Daitoh H Furumoto Y Kishi T Mori, Gynecol Oncol 1986 25 2 195 203 10.1016/0090-8258(86)90099-5 3758829
44. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. AT Lorincz R Reid AB Jenson MD Greenberg W Lancaster RJ Kurman, Obstet Gynecol 1992 79 3 328 337 Comment in: Obstet Gynecol. 2003, 102(6) :1224. 1310805
45. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. LA Koutsky KK Holmes CW Critchlow CE Stevens J Paavonen AM Beckmann TA DeRouen DA Galloway D Vernon NB Kiviat, N Engl J Med 1992 327 18 1272 1278 1328880
46. Expression of the proliferating cell nuclear antigen in cervical neoplasia. GC Raju, Int J Gynecol Pathol 1994 13 4 337 341 7814195
47. Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri. R Holm H Skomedal A Helland G Kristensen AL Børresen JM Nesland, J Pathol 1993 169 1 21 26 10.1002/path.1711690105 8433212